Pharma / 12.07.2018

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company’s talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.   For further information, see the articles listed below: https://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit/jury-orders-jj-to-pay-4-7-billion-in-missouri-asbestos-cancer-case-idUSKBN1K234U https://www.nytimes.com/2018/07/12/business/johnson-johnson-talcum-powder.html http://www.chemdiv.com/jury-orders-jj-pay-4-7-billion-missouri-asbestos-cancer-case/...

Companies / 30.05.2015

After a year, it is time to look back and make some considerations about the deal that never happened in Pharma industry.   For further information, see the articles listed below: http://www.ft.com/intl/cms/s/0/e8320ccc-0327-11e5-8333-00144feabdc0.html?o=clippings/list#axzz3bd1cPd77 https://www.theguardian.com/business/2014/may/19/pfizer-failed-takeover-bid-astrazeneca https://www.reuters.com/article/us-astrazeneca-pfizer/pfizer-walks-away-from-118-billion-astrazeneca-takeover-fight-idUSBREA3R0H520140526...

Pharma / 19.09.2014

GlaxoSmithKline still has questions to answer over bribery case in China. In 2013 Chinese police accused dozens of GSK employees, including Mark Reilly, its former China CEO, of fraudulent practices and briberies worth billions of dollars to doctors and officials around the country. The British pharmaceutical...